Axel Bolte
2020
In 2020, Axel Bolte earned a total compensation of $5.4M as President and Chief Executive Officer at Inozyme Pharma, a 452% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $290,466 |
|---|---|
| Option Awards | $4,584,236 |
| Salary | $440,099 |
| Other | $40,833 |
| Total | $5,355,634 |
Bolte received $4.6M in option awards, accounting for 86% of the total pay in 2020.
Bolte also received $290.5K in non-equity incentive plan, $440.1K in salary and $40.8K in other compensation.
Rankings
In 2020, Axel Bolte's compensation ranked 2,024th out of 13,090 executives tracked by ExecPay. In other words, Bolte earned more than 84.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,024 out of 13,090 | 85th |
Division Manufacturing | 781 out of 5,624 | 86th |
Major group Chemicals And Allied Products | 279 out of 2,257 | 88th |
Industry group Drugs | 235 out of 1,957 | 88th |
Industry Pharmaceutical Preparations | 165 out of 1,462 | 89th |
Source: SEC filing on April 27, 2021.
Bolte's colleagues
We found two more compensation records of executives who worked with Axel Bolte at Inozyme Pharma in 2020.